Fore Capital, LLC Biomerica Inc Transaction History

Fore Capital, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$0.82 - $1.29 $20,500 - $32,250	25,000 Added 72.09%	59,680 $49,000
Q4 2023 Feb 13, 2024	BUY	$0.71 - $1.65 $10,650 - $24,750	15,000 Added 76.22%	34,680 $43,000
Q3 2023 Nov 06, 2023	SELL	$0.82 - $1.65 $821 - $1,653	-1,002 Reduced 4.84%	19,680 $16,000
Q2 2023 Aug 09, 2023	SELL	$1.12 - $1.87 $32,477 - $54,226	-28,998 Reduced 58.37%	20,682 $28,000
Q1 2023 May 09, 2023	BUY	$1.86 - $3.56 $37,200 - $71,200	20,000 Added 67.39%	49,680 $92,000
Q4 2022 Feb 13, 2023	SELL	$2.98 - $4.17 $65,560 - $91,740	-22,000 Reduced 42.57%	29,680 $99,000
Q3 2022 Nov 10, 2022	SELL	$2.61 - $3.98 $86,965 - $132,613	-33,320 Reduced 39.2%	51,680 $203,000
Q4 2021 Feb 11, 2022	SELL	$3.89 - $6.71 $194,500 - $335,500	-50,000 Reduced 37.04%	85,000 $331,000
Q2 2021 Aug 12, 2021	BUY	$3.41 - $5.9 $197,292 - $341,356	57,857 Added 75.0%	135,000 $541,000
Q1 2021 May 17, 2021	BUY	$5.06 - $8.0 $390,343 - $617,144	77,143 New	77,143 $421,000

1.59M

23.3K

Ticker BMRA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 13,427,700
Market Cap $10.5M
Description
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various disea...

Get notified when there are updates to the investment portfolio of Fore Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fore Capital, LLC with notifications on news.